» Sign in / Register


Interleukin 3, mast cell growth factor

human, recombinant, E. coli

Cat. No. Amount Price (EUR) Buy / Note
PR-462 10 μg 253,00 Add to Basket/Quote Add to Notepad

For in vitro use only!

Shipping: shipped at ambient temperature

Storage Conditions: store at -20 °C
avoid freeze/thaw cycles

Shelf Life: 12 months

Molecular Weight: 15 kDa

Accession number: P08700

Accession number: P08700

Purity: > 95 % (SDS-PAGE, RP-HPLC)

Form: lyophilised

Solubility: It is recommended to reconstitute the lyophilised IL-3 in bidest H2O not less than 100 μg/ml, which can then be further diluted to other aqueous solutions. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).

Activity: ED50: < 0.1 ng/ml, corresponding to a specific activity of 2 x 106 IU/mg, determined by the dosedependent stimulation of TF-1 cells.

Interleukin-3 (IL-3) is a cytokine produced by activated T-cells and mast cells that has been shown to stimulate renewal of pluripotent hematopoietic stem cells and to be a potent regulator of many hematopoietic cell lineages. It is involved in stimulating inducible hematopoiesis in response to parasite infections, and it has also been implicated in the pathogenesis of several chronic inflammatory diseases, including asthma, and neurodegenerative disorders, such as multiple sclerosis. Recombinant human IL-3 produced in E. coli is a single, non-glycosylated form of human IL-3 polypeptide chain containing 133 amino acids and having a molecular mass of 15 kDa. IL-3 is purified by proprietary chromatographic techniques.

Endotoxin: Less than 0.1 ng/μg (IEU/μg) of IL-3.

Selected References:
Murphy et al. (2004) Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains. J. Biol. Chem. 279:26500.
Cohen et al. (2004) Toxicology and pharmacokinetics of DT388IL3, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human interleukin 3 (IL3), in cynomolgus monkeys. Leuk. Lymphoma. 45:1647.
Ding et al. (2003) Molecular cloning, expression, purification, and characterization of soluble full-length, human interleukin-3 with a baculovirus-insect cell expression system. Protein Expr. Purif. 31:34.
Biesma et al. (2002) Recombinant human interleukin-3 administered concomitantly with chemotherapy in patients with relapsed small cell lung cancer. J. Exp. Ther. Oncol. 2:47.
Zanetta et al. (2002) Evidence for a lectin activity for human interleukin 3 and modeling of its carbohydrate recognition domain. J. Biol. Chem. 277:38764.